This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jul 24;398(10297):302.

doi: 10.1016/S0140-6736(21)00876-X.

Heterogeneity of treatment effects in malignant pleural mesothelioma - Authors' reply

Paul Baas¹, Arnaud Scherpereel², Anna K Nowak³, Abderrahim Oukessou⁴, Gerard Zalcman⁵

Affiliations

Affiliations

¹ Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: p.baas@nki.nl.
² Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, Lille, France.
³ Medical School, University of Western Australia, Perth, WA, Australia.
⁴ Bristol Myers Squibb, Princeton, NJ, USA.
⁵ Bichat-Claude Bernard University Hospital, Université de Paris, Paris, France.

PMID: 34303436
DOI: 10.1016/S0140-6736(21)00876-X

Comment

Heterogeneity of treatment effects in malignant pleural mesothelioma - Authors' reply

Paul Baas et al. Lancet. 2021.

. 2021 Jul 24;398(10297):302.

doi: 10.1016/S0140-6736(21)00876-X.

Authors

Paul Baas¹, Arnaud Scherpereel², Anna K Nowak³, Abderrahim Oukessou⁴, Gerard Zalcman⁵

Affiliations

¹ Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: p.baas@nki.nl.
² Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, Lille, France.
³ Medical School, University of Western Australia, Perth, WA, Australia.
⁴ Bristol Myers Squibb, Princeton, NJ, USA.
⁵ Bichat-Claude Bernard University Hospital, Université de Paris, Paris, France.

PMID: 34303436
DOI: 10.1016/S0140-6736(21)00876-X

No abstract available

PubMed Disclaimer

Conflict of interest statement

A summary of competing interests in available in the appendix.

Comment on

Heterogeneity of treatment effects in malignant pleural mesothelioma.
Di Maio M, Tagliamento M. Di Maio M, et al. Lancet. 2021 Jul 24;398(10297):301-302. doi: 10.1016/S0140-6736(21)00882-5. Lancet. 2021. PMID: 34303435 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information